What type of Pneumovax (Pneumococcal vaccine) is recommended for a 24-year-old with a history of pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 24-year-old with a history of pneumonia and no other specified underlying medical conditions, no pneumococcal vaccine is routinely recommended. However, if the individual has certain risk factors such as chronic heart, lung, or liver disease, diabetes, immunocompromising conditions, cochlear implants, or cerebrospinal fluid leaks, then pneumococcal vaccination would be recommended. According to the most recent guidelines from 2024 1, for adults aged 19-64 years with an immunocompromising condition, a single dose of PCV21, PCV20, or PCV15 is recommended. If PCV15 is used, a single dose of PPSV23 should be administered ≥8 weeks after the PCV15 dose. Key considerations include:

  • The individual's complete medical history
  • The presence of any immunocompromising conditions
  • The specific vaccine options available, such as PCV21, PCV20, or PCV15, and PPSV23 It's essential to consult with a healthcare provider for personalized recommendations based on the individual's unique situation, as guidelines may evolve, and individual circumstances can affect the best course of action, as noted in recent studies 1.

From the Research

Pneumovax Recommendations

The type of Pneumovax recommended for a 24-year-old with a history of pneumonia is not directly stated in the provided studies. However, based on the available information:

  • The Advisory Committee on Immunization Practices (ACIP) recommends PCV13 for adults aged ≥65 years and immunocompromised adults aged <65 years 2, 3.
  • For adults aged <50 years, PCV13 is not recommended for immunocompetent adults with comorbidities associated with increased pneumococcal disease risk 3.
  • There is no specific recommendation for a 24-year-old with a history of pneumonia, as the studies focus on older adults or those with underlying medical conditions.

Vaccine Options

The available vaccine options are:

  • 13-valent pneumococcal conjugate vaccine (PCV13)
  • 23-valent pneumococcal polysaccharide vaccine (PPSV23)
  • Sequential PCV13/PPSV23 vaccination

Effectiveness of Vaccines

The effectiveness of these vaccines in preventing pneumococcal pneumonia is:

  • PCV13: shown to be effective in preventing vaccine-type community-acquired pneumonia in adults aged ≥65 years 4
  • PPSV23: has a lower effectiveness in preventing pneumococcal pneumonia compared to PCV13 5, 4
  • Sequential PCV13/PPSV23 vaccination: shown to be the most effective in preventing pneumococcal CAP among adults aged 65-74 years 5

Considerations for Younger Adults

For younger adults, such as the 24-year-old in question:

  • PCV13 has demonstrated efficacy against VT-IPD and pneumonia in adults aged ≥65 years, and immune responses to PCV13 in younger adults are comparable or better than in older adults 3
  • However, there is no direct recommendation for PCV13 use in healthy adults aged <50 years 3

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the recommended pneumococcal vaccine (Pneumococcal Conjugate Vaccine (PCV) or Pneumococcal Polysaccharide Vaccine (PPSV)) regimen for adults?
Should an 86-year-old patient who received Pneumovax (pneumococcal polysaccharide vaccine) 27 years ago get the new PCV23 (pneumococcal conjugate vaccine)?
After completing treatment for an acute episode of pneumonia, when can the pneumococcal vaccine (PCV13 or PPSV23) be administered?
As an elderly male in his late 80s who has received three or four pneumococcal vaccinations (including PCV13 and PPSV23) over the past decade, with the most recent dose about two years ago, is it appropriate to receive another pneumococcal vaccine now?
At what age and frequency should a 53-year-old individual receive the pneumococcal (pneumonia) vaccine, specifically the pneumococcal conjugate vaccine (PCV13 or Prevnar 13) and the pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax23)?
What is the workup for suspected stenosis of the right common iliac artery?
What is the significance of a cervical length of 9mm at 31 weeks and 5 days gestation?
Can nicotine replacement therapy (NRT) be used with varenicline (Chantix)?
Which nerve provides sensation to the piriform recess?
What are the treatment options for nerve damage caused by cold exposure?
What oral antibiotic (abx) would be most appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question